Czech National Bank Laboratory Corp Of America Holdings Transaction History

Czech National Bank

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 10, 2024	BUY	$209.01 - $232.56 $14,212 - $15,814	68 Added 0.46%	14,938 $3.26 Million
Q4 2023 Jan 08, 2024	SELL	$197.69 - $227.29 $121,777 - $140,010	-616 Reduced 3.98%	14,870 $3.38 Million
Q3 2023 Oct 19, 2023	BUY	$201.05 - $221.7 $1 Million - $1.11 Million	4,998 Added 47.65%	15,486 $3.11 Million
Q2 2023 Jul 11, 2023	BUY	$211.93 - $241.33 $11,656 - $13,273	55 Added 0.53%	10,488 $2.53 Million
Q1 2023 Apr 17, 2023	BUY	$213.32 - $257.83 $13,225 - $15,985	62 Added 0.6%	10,433 $2.39 Million

Q4 2022 Jan 18, 2023	SELL	$203.72 - $248.97 $27,502 - $33,610	-135 Reduced 1.28%	10,371 $0
Q3 2022 Oct 31, 2022	BUY	$204.81 - $262.19 $2.15 Million - $2.75 Million	10,506 New	10,506 $2.15 Million

868

74.6M

265K

189K

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $18.9B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Czech National Bank, based on Form 13F filings with the SEC.

Stay updated on Czech National Bank with notifications on news.